報價延遲最少15分鐘:2026/11/04 21:22 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
19.29 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.12/--
|
|
企業價值
5.33B
|
| 資產負債 |
|
每股賬面淨值
12.87
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
2.72B
|
|
每股收益
0.44
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables. |
